TITLE

Toxoplasma seropositivity and depression: a case report

AUTHOR(S)
Kar, Nilamadhab; Misra, Baikunthanath
PUB. DATE
January 2004
SOURCE
BMC Psychiatry;2004, Vol. 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Background: The association between toxoplasmosis and psychiatric disorders has been reported in a few anecdotal reports. Case Presentation: A case of depression with toxoplasma seropositivity is presented. The patient with depression showed poor response to antidepressants, for which he was investigated and was found positive on the serological test for the toxoplasma. The response to antidepressant treatment improved only after adequate treatment for toxoplasma. Conclusions: The case suggests a probable association between toxoplasmosis and depression.
ACCESSION #
29323642

 

Related Articles

  • Depression: How Medicine Can Help.  // American Family Physician;3/1/2000, Vol. 61 Issue 5, special section p1 

    Reveals how medicine can help depression, a mental illness like diabetes or high blood pressure. Causes of depression; Treatment for depression; Things considered by doctor before choosing antidepressant medicine for depressed persons; Different kinds of antidepressants.

  • Repetitive Transcranial Magnetic Stimulation: Does it Have Potential in the Treatment of Depression? Padberg, Frank; Möller, Hans-Jürgen // CNS Drugs;2003, Vol. 17 Issue 6, p383 

    Transcranial magnetic stimulation (TMS) has become a major research tool in experimental clinical neurophysiology as a result of its potential to noninvasively and focally stimulate cortical brain regions. Currently, studies are being conducted to investigate whether repetitive TMS...

  • The Human Cost of Not Achieving Full Remission in Depression. McIntyre, Roger S.; O'Donovan, Claire // Canadian Journal of Psychiatry;Mar2004 Supplement, Vol. 49, p10S 

    Depression is among the most disabling and costly illnesses in the world. Despite good short-term efficacy outcomes in the treatment of depression, long-term outcomes remain disappointing. Depression continues to be missed or underdiagnosed and undertreated, and comorbidities are frequently not...

  • Antidepressant utilization in Canada. Beck, Cynthia A.; Patten, Scott B.; Williams, Jeanne V. A.; Jian Li Wang; Currie, Shawn R.; Maxwell, Colleen J.; El-Guebaly, Nady // Social Psychiatry & Psychiatric Epidemiology;Oct2005, Vol. 40 Issue 10, p799 

    Objective Antidepressant utilization can be used as an indicator of appropriate treatment for major depression. The objective of this study was to characterize antidepressant utilization in Canada, including the relationships of antidepressant use with sociodemographic variables, past-year and...

  • Attitudes towards people with mental disorders: the psychometric characteristics of a Finnish questionnaire. Aromaa, Esa; Tolvanen, Asko; Tuulari, Jyrki; Wahlbeck, Kristian // Social Psychiatry & Psychiatric Epidemiology;Feb2010, Vol. 45 Issue 2, p265 

    The prevalence of mental disorders, especially depression, increasingly creates concern for our mental, social and economic well-being. The public has insufficient knowledge about mental disorders and their treatment. A stigma is attached to mental disorders, which has a multifaceted impact on...

  • The Third Category of Mental Disorders. Youxin Xu // Culture, Medicine & Psychiatry;Dec2009, Vol. 33 Issue 4, p496 

    The article discusses the third category of mental disorders which are known as the nonorganic, nonpsychotic mental disorders. Organic mental disorders and psychotic disorders are the other categories of mental disorders. Subcategories of organic mental disorders and psychotic disorders are...

  • Use of a Second Generation Antipsychotic among Patients Diagnosed with Major Depressive Disorder in the United States. Sclar, David A.; Robison, Linda M.; Cohen, Lawrence J.; Laubmeie, Kimberly K.; Kalsekar, Iflekhar D.; Forbes, Robert A. // Pharmaceutical Medicine - New Zealand;2012, Vol. 26 Issue 4, p235 

    Purpose: The purpose of the study was to discern the extent of the prescribing of a second generation atypical antipsychotic (SGA), either alone or in combination with an antidepressant, among patients diagnosed with major depressive disorder (MDD) in the US, and the influence of physician...

  • Situación actual del tratamiento a largo plazo de la depresión. Ruiloba, J. Vallejo // Actas Espanolas de Psiquiatria;sep2007, Vol. 35 Issue 5, p285 

    Depression is the most common mental illness and the primary cause of disability. Currently, major depression is considered a chronic disorder, with very high lifetime recurrence rates. This article reviews the published literature on long-term treatment of depression, with special emphasis on...

  • Depressive Classification and Prediction of Response to Phenelzine. Paykel, E. S.; Parker, R. R.; Penrose, R. J. J.; Rassaby, E. R. // British Journal of Psychiatry;Jun79, Vol. 134, p572 

    A variety of depressive classifications were used to predict response to four weeks' treatment with phenelzine. Better response was found in outpatients rather than inpatients, in atypical depressives, in less severe depressives with a pattern of anxiety and other neurotic symptoms, and in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics